Price Alert

Prime Medicine Inc. (PRME)

NASDAQ: PRME · Real-Time Price · USD

3.62

-0.02 (-0.55%)

At close: Aug 15, 2025, 12:50 PM

Prime Medicine Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Mar 31, 2021
Cash & Equivalents	53.8M	91.88M	182.48M	117.98M	55.6M	94.16M	41.57M	43.96M	120.58M	133.46M	187.62M	47.95M	92.24M	164.25M	185.42M	200.66M	-53.33M
Short-Term Investments	44.54M	52.38M	7.97M	57.55M	107.27M	116.56M	80.09M	121.36M	87.04M	116.06M	106.3M	98.72M	88.36M	47.02M	84.2M	99.26M	106.66M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	13.5M	13.5M	-4.82M	-6.4M	-6.13M	n/a	13.5M	13.5M	13.13M	13.13M	n/a	n/a
Other Long-Term Assets	13.69M	14.06M	14.06M	14.06M	13.5M	779K	14.28M	20.13M	32.58M	25.26M	15.14M	5.61M	4.87M	3.8M	2.47M	794K	-53.33M
Receivables	n/a	17K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	22.94M	16.54M	14.67M	64.54M	3.74M	2.73M	2.25M	19.21M	10.87M	3.98M	246K	n/a	n/a	690K	959K	485K	n/a
Total Current Assets	121.29M	163.76M	211.89M	246.07M	170.8M	217.65M	142.98M	184.53M	207.62M	249.52M	296.62M	148.84M	181.6M	211.96M	270.58M	300.41M	53.33M
Property-Plant & Equipment	144.03M	150.34M	71.56M	72.65M	75.41M	79.45M	36.6M	39.3M	47.06M	48.3M	48.55M	47.31M	47.63M	15.67M	15.68M	13.99M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	-136.54M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	157.72M	164.4M	85.62M	86.71M	88.9M	93.73M	50.88M	54.61M	73.25M	67.43M	63.7M	66.42M	65.99M	32.59M	31.28M	14.78M	-53.33M
Total Assets	279.01M	328.16M	297.51M	332.78M	259.7M	311.38M	193.85M	239.15M	280.87M	316.95M	360.31M	215.26M	247.6M	244.55M	301.86M	315.19M	n/a
Account Payables	6.38M	10.03M	11.35M	5.43M	4.64M	10.08M	19.54M	14.12M	5.49M	4.56M	4.33M	4.11M	5.88M	3.2M	1.44M	1.36M	n/a
Deferred Revenue	8.31M	8.21M	7.09M	9.28M	n/a	n/a	26M	13.18M	8.92M	n/a	n/a	n/a	n/a	n/a	36.91M	n/a	n/a
Short-Term Debt	7.26M	n/a	n/a	n/a	5.22M	n/a	9.28M	11.22M	13.51M	11.77M	n/a	11.58M	n/a	6.01M	n/a	n/a	n/a
Other Current Liabilities	12.16M	6.9M	10.25M	18.68M	742K	4.55M	10.06M	-2.83M	-8.24M	-6.46M	6.98M	-7.28M	1.19M	3.69M	14.66M	8.19M	n/a
Total Current Liabilities	34.11M	34.29M	37.96M	37.88M	20.75M	24.44M	56.42M	39.37M	28.72M	23.87M	26.71M	22.22M	23.83M	12.89M	57.98M	9.54M	n/a
Long-Term Debt	112.48M	n/a	n/a	n/a	36.37M	n/a	4.36M	5.82M	11.93M	14.2M	n/a	19.86M	n/a	2.09M	n/a	4.27M	n/a
Other Long-Term Liabilities	71.56M	n/a	6M	n/a	-30.37M	n/a	-4.36M	-5.82M	-11.93M	-14.2M	n/a	-19.86M	n/a	-1.38M	n/a	-4.27M	n/a
Total Long-Term Liabilities	184.04M	186.95M	106.4M	105.4M	42.37M	43.18M	4.36M	5.82M	12.04M	14.27M	17.33M	20.34M	23.03M	2.8M	4.31M	4.27M	n/a
Total Liabilities	218.15M	221.24M	144.36M	143.28M	63.12M	67.62M	60.78M	45.19M	40.76M	38.15M	44.04M	42.56M	46.86M	15.69M	62.3M	13.81M	n/a
Total Debt	119.74M	121.15M	40.79M	41.25M	41.58M	43.79M	13.63M	17.04M	25.44M	25.96M	28.75M	31.44M	34.72M	8.1M	10.41M	9.74M	n/a
Common Stock	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	2K	n/a	n/a	1K	1K	1K	n/a
Retained Earnings	-791.69M	-739.1M	-687.21M	-644.94M	-592.42M	-537.09M	-491.33M	-425.69M	-374.98M	-332.59M	-293.2M	-253.91M	-224.56M	-195.22M	-171.38M	-108.47M	n/a
Comprehensive Income	-10K	-15K	1K	21K	-71K	-95K	-15K	-149K	-268K	-205K	-384K	-454K	-150K	-32K	-27K	-9K	2.34M
Shareholders Equity	60.86M	106.92M	153.15M	189.5M	196.59M	243.77M	133.07M	193.96M	240.1M	278.8M	316.27M	172.7M	200.74M	228.86M	239.56M	301.38M	33.47M
Total Investments	n/a	52.38M	7.97M	57.55M	107.27M	130.06M	80.09M	116.54M	80.64M	109.92M	106.3M	98.72M	88.36M	60.14M	84.2M	99.26M	106.66M